Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1955 1
1956 2
1957 1
1958 4
1959 2
1961 1
1962 3
1963 3
1964 1
1965 4
1966 3
1967 2
1968 1
1970 2
1971 1
1972 1
1973 1
1974 3
1975 6
1976 2
1977 4
1978 7
1979 3
1980 8
1981 5
1982 10
1983 11
1984 8
1985 5
1986 5
1987 10
1988 6
1989 6
1990 7
1991 2
1992 2
1993 11
1994 4
1995 10
1996 14
1997 5
1998 9
1999 2
2000 8
2001 9
2002 9
2003 12
2004 19
2005 9
2006 4
2007 12
2008 7
2009 7
2010 2
2011 10
2012 14
2013 16
2014 18
2015 22
2016 10
2017 27
2018 41
2019 52
2020 46
2021 49
2022 44
2023 39
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

641 results

Results by year

Filters applied: . Clear all
Page 1
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M; ADVOR Study Group. Mullens W, et al. Among authors: dupont m. N Engl J Med. 2022 Sep 29;387(13):1185-1195. doi: 10.1056/NEJMoa2203094. Epub 2022 Aug 27. N Engl J Med. 2022. PMID: 36027559 Clinical Trial.
Identification of essential sites of lipid peroxidation in ferroptosis.
von Krusenstiern AN, Robson RN, Qian N, Qiu B, Hu F, Reznik E, Smith N, Zandkarimi F, Estes VM, Dupont M, Hirschhorn T, Shchepinov MS, Min W, Woerpel KA, Stockwell BR. von Krusenstiern AN, et al. Among authors: dupont m. Nat Chem Biol. 2023 Jun;19(6):719-730. doi: 10.1038/s41589-022-01249-3. Epub 2023 Feb 6. Nat Chem Biol. 2023. PMID: 36747055 Free PMC article.
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Mullens W, Dauw J, Martens P, Meekers E, Nijst P, Verbrugge FH, Chenot F, Moubayed S, Dierckx R, Blouard P, Derthoo D, Smolders W, Ector B, Hulselmans M, Lochy S, Raes D, Van Craenenbroeck E, Vandekerckhove H, Hofkens PJ, Goossens K, Pouleur AC, De Ceuninck M, Gabriel L, Timmermans P, Prihadi EA, Van Durme F, Depauw M, Vervloet D, Viaene E, Vachiery JL, Tartaglia K, Ter Maaten JM, Bruckers L, Droogne W, Troisfontaines P, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M. Mullens W, et al. Among authors: dupont m. Eur J Heart Fail. 2022 Sep;24(9):1601-1610. doi: 10.1002/ejhf.2587. Epub 2022 Jul 12. Eur J Heart Fail. 2022. PMID: 35733283 Free article. Clinical Trial.
Lys i mørket.
Dupont M. Dupont M. Ugeskr Laeger. 2018 Oct 1;180(40):V70024. Ugeskr Laeger. 2018. PMID: 30274576 Free article. Danish. No abstract available.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Lawson M, Cureton N, Ros S, Cheraghchi-Bashi A, Urosevic J, D'Arcy S, Delpuech O, DuPont M, Fisher DI, Gangl ET, Lewis H, Trueman D, Wali N, Williamson SC, Moss J, Montaudon E, Derrien H, Marangoni E, Miragaia RJ, Gagrica S, Morentin-Gutierrez P, Moss TA, Maglennon G, Sutton D, Polanski R, Rosen A, Cairns J, Zhang P, Sánchez-Guixé M, Serra V, Critchlow SE, Scott JS, Lindemann JPO, Barry ST, Klinowska T, Morrow CJ, Carnevalli LS. Lawson M, et al. Among authors: dupont m. Cancer Res. 2023 Dec 1;83(23):3989-4004. doi: 10.1158/0008-5472.CAN-23-0694. Cancer Res. 2023. PMID: 37725704 Free PMC article.
Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
Martens P, Dauw J, Verbrugge FH, Nijst P, Meekers E, Augusto SN Jr, Ter Maaten JM, Damman K, Mebazaa A, Filippatos G, Ruschitzka F, Tang WHW, Dupont M, Mullens W. Martens P, et al. Among authors: dupont m. Circulation. 2023 Jan 17;147(3):201-211. doi: 10.1161/CIRCULATIONAHA.122.062486. Epub 2022 Nov 6. Circulation. 2023. PMID: 36335479 Clinical Trial.
Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
Mullens W, Verbrugge FH, Nijst P, Martens P, Tartaglia K, Theunissen E, Bruckers L, Droogne W, Troisfontaines P, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M. Mullens W, et al. Among authors: dupont m. Eur J Heart Fail. 2018 Nov;20(11):1591-1600. doi: 10.1002/ejhf.1307. Epub 2018 Sep 21. Eur J Heart Fail. 2018. PMID: 30238574 Free article. Clinical Trial.
641 results